ES2181663T3 - Procedimiento para la preparacion de citalopram puro. - Google Patents

Procedimiento para la preparacion de citalopram puro.

Info

Publication number
ES2181663T3
ES2181663T3 ES01913727T ES01913727T ES2181663T3 ES 2181663 T3 ES2181663 T3 ES 2181663T3 ES 01913727 T ES01913727 T ES 01913727T ES 01913727 T ES01913727 T ES 01913727T ES 2181663 T3 ES2181663 T3 ES 2181663T3
Authority
ES
Spain
Prior art keywords
citalopram
preparation
cyanide
subjected
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01913727T
Other languages
English (en)
Inventor
Andrea Castellin
Giulio Volpe
Federico Sbrogio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Application granted granted Critical
Publication of ES2181663T3 publication Critical patent/ES2181663T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un procedimiento para la preparación de citalopram de fórmula en el que un compuesto de fórmula II en donde Z es yodo, bromo, cloro o CF3-(CF2)n-S02-0-, siendo n 0, 1, 2, 3, 4, 5, 6, 7 u 8, se somete a una reacción de intercambio con cianuro, en el que el grupo Z se intercambia con cianuro mediante la reacción con una fuente de cianuro; el producto de citalopram bruto resultante se somete, opcionalmente, a una cierta purificación inicial, y la base de citalopram bruta se somete, subsiguientemente, a un proceso de destilación en película; el producto de citalopram resultante se purifica entonces, opcionalmente, de forma adicional y se elabora y aísla en forma de la base o una sal farmacéuticamente aceptable del mismo.
ES01913727T 2000-12-28 2001-03-07 Procedimiento para la preparacion de citalopram puro. Expired - Lifetime ES2181663T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200001943 2000-12-28

Publications (1)

Publication Number Publication Date
ES2181663T3 true ES2181663T3 (es) 2003-03-01

Family

ID=8159933

Family Applications (2)

Application Number Title Priority Date Filing Date
ES01913727T Expired - Lifetime ES2181663T3 (es) 2000-12-28 2001-03-07 Procedimiento para la preparacion de citalopram puro.
ES200101763A Expired - Lifetime ES2170733B1 (es) 2000-12-28 2001-07-27 Metodo para preparar citalopram purificado

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES200101763A Expired - Lifetime ES2170733B1 (es) 2000-12-28 2001-07-27 Metodo para preparar citalopram purificado

Country Status (41)

Country Link
US (2) US6855834B2 (es)
EP (1) EP1181272B1 (es)
JP (1) JP2003519121A (es)
KR (1) KR100430746B1 (es)
CN (1) CN1366526A (es)
AR (1) AR029898A1 (es)
AT (2) ATE222899T1 (es)
AU (3) AU2001100399B4 (es)
BE (2) BE1013417A6 (es)
BG (1) BG106219A (es)
BR (1) BR0106271A (es)
CA (1) CA2359810C (es)
CH (1) CH691536A5 (es)
CZ (1) CZ293140B6 (es)
DE (1) DE60100016T2 (es)
DK (1) DK1181272T3 (es)
EA (1) EA003459B1 (es)
ES (2) ES2181663T3 (es)
FI (2) FI108640B (es)
FR (1) FR2818977B1 (es)
GB (2) GB2356199B (es)
GR (1) GR20010100131A (es)
HK (1) HK1049332A1 (es)
HR (1) HRP20020005A2 (es)
HU (2) HU0101028D0 (es)
IE (2) IES20010253A2 (es)
IL (1) IL147162A0 (es)
IS (1) IS5884A (es)
IT (1) ITMI20010604A1 (es)
MX (1) MXPA01013336A (es)
NL (1) NL1017534C1 (es)
NO (1) NO313047B1 (es)
NZ (1) NZ516299A (es)
PL (1) PL353369A1 (es)
PT (1) PT1181272E (es)
SE (1) SE0103044L (es)
SK (1) SK284418B6 (es)
TR (1) TR200200018T1 (es)
UA (1) UA71635C2 (es)
WO (1) WO2001047877A2 (es)
ZA (1) ZA200110133B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319073A1 (es) * 2005-06-22 2009-05-01 H. Lundbeck A/S Base cristalina de escitalopram y comprimidos orodispersables que comprenden la base de escitalopram.

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
TR200102957T2 (tr) 1999-04-14 2004-12-21 H. Lundbeck A/S Sitalopram hazırlanması için metod.
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
EP1228056B1 (en) 1999-10-25 2004-09-22 H. Lundbeck A/S Method for the preparation of citalopram
HRP20020344B1 (hr) 1999-10-25 2010-10-31 H. Lundbeck A/S Način priprave citaloprama
AR026063A1 (es) 1999-11-01 2002-12-26 Lundbeck & Co As H Metodo para la preparacion de 5-carboxiftalida.
EP1246812B1 (en) 1999-12-28 2004-03-17 H. Lundbeck A/S Method for the preparation of citalopram
SI1246813T1 (en) 1999-12-30 2004-08-31 H. Lundbeck A/S Method for the preparation of citalopram
PL197821B1 (pl) 2000-01-14 2008-04-30 Lundbeck & Co As H Sposób wytwarzania 5-cyjanoftalidu
NL1017417C1 (nl) 2000-03-03 2001-03-16 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
PL360110A1 (en) 2000-03-13 2004-09-06 H.Lundbeck A/S Method for the preparation of citalopram
BR0109364A (pt) * 2000-03-13 2002-12-24 Lundbeck & Co As H Métodos para fabricação de citalopram através de alquilação escalonada de 5-substituìda 1- (4-fluorofenil) - 1,3- diidroisobenzofuranos e citalopram
NL1017500C1 (nl) 2000-03-13 2001-04-26 Lundbeck & Co As H Werkwijze voor de bereiding van Citalopram.
JP2003527386A (ja) 2000-03-14 2003-09-16 ハー・ルンドベック・アクチエゼルスカベット シタロプラムの製造方法
CH692148A5 (de) * 2000-03-16 2002-02-28 Lundbeck & Co As H Verfahren zur Herstellung von Citalopram.
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
CA2354877C (en) 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
EA003581B1 (ru) 2000-12-22 2003-06-26 Х.Лундбекк А/С Способ получения чистого циталопрама
AU2001100399B4 (en) 2000-12-28 2002-03-21 H Lundbeck As Process for the preparation of pure citalopram
GB2376945A (en) * 2001-06-27 2002-12-31 Cipla Ltd Citalopram preparation
AU2003222435A1 (en) 2002-01-07 2003-07-24 Sun Pharmaceutical Industries Limited Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
ES2194597B2 (es) * 2002-01-25 2004-08-01 Esteve Quimica, S.A. Procedimiento para la obtencion de citalopram.
GB0204607D0 (en) 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2386119A (en) * 2002-02-27 2003-09-10 Cipla Ltd Purification of citalopram
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
WO2004085416A1 (en) * 2003-03-24 2004-10-07 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US7019153B2 (en) 2003-06-10 2006-03-28 Sun Pharmaceutical Industries Limited Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
CN100569765C (zh) 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL135959C (es) 1964-12-23
GB1143703A (es) * 1965-03-18
DE1619713A1 (de) * 1967-03-29 1970-12-17 Leybold Heraeus Gmbh & Co Kg Vorrichtung zur Vakuum- und Kurzwegdestillation
DE2135085C3 (de) 1971-07-14 1981-12-03 Basf Ag, 6700 Ludwigshafen Verfahren zur Wiedergewinnung von Caprolactam aus einem Gemisch, das Caprolactam und dessen Oligomere enthält
DE2442426C2 (de) * 1974-09-05 1983-04-07 Bayer Ag, 5090 Leverkusen Diisocyanatodiketene, Verfahren zu deren Herstellung und deren Verwendung
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
IT8020902A0 (it) 1980-03-25 1980-03-25 Snia Viscosa Procedimento ed apparecchiatura per la separazione continua per via termica di miscele liquide dicomposti termolabili.
JPS6082101A (ja) 1983-10-13 1985-05-10 Mitsui Toatsu Chem Inc 高沸点重合性化合物の薄膜蒸留による精製方法
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
FR2656305B1 (fr) 1989-12-22 1992-04-10 Norsolor Sa Procede de purification du (meth)acrylate de glycidyle.
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
US5582692A (en) 1994-10-07 1996-12-10 Artisan Industries, Inc. Method for the purification of vitamin E
US6136991A (en) * 1996-05-21 2000-10-24 Exxon Chemical Patents Inc. Glycidyl ester adducts having increased glass transition temperatures
DE69725717T2 (de) 1996-05-21 2004-07-29 Exxonmobil Chemical Patents Inc., Baytown Reinigung von glycidylestern durch dünnschichtverdampfung
DE19626659A1 (de) * 1996-07-03 1998-01-08 Basf Ag Verfahren zur Herstellung von Phthaliden
DE19627697A1 (de) * 1996-07-10 1998-01-15 Basf Ag Verfahren zur Herstellung von Phthaliden
CN1206207C (zh) 1997-07-08 2005-06-15 H.隆德贝克有限公司 氰酞氟苯胺的制备方法
DE19734673A1 (de) * 1997-08-11 1999-02-18 Rwe Dea Ag Verfahren zur Herstellung von metallfreien Guerbetalkoholen
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
HUP0002953A3 (en) 1997-11-11 2002-12-28 Lundbeck & Co As H Method for preparation of citalopram and intermediates used for them
EP0965593B2 (en) * 1998-06-19 2008-12-03 Shin-Etsu Chemical Co., Ltd. Distillation of (meth)acryloxybearing alkoxysilane
DE69904853T2 (de) * 1998-10-20 2003-09-04 Lundbeck As Valby H Verfahren zur herstellung von citalopram
SI1140886T1 (en) 1998-12-23 2003-08-31 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
AR022329A1 (es) 1999-01-29 2002-09-04 Lundbeck & Co As H Metodo para la preparacion de 5-cianoftalida
TR200102957T2 (tr) 1999-04-14 2004-12-21 H. Lundbeck A/S Sitalopram hazırlanması için metod.
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
EP1228056B1 (en) 1999-10-25 2004-09-22 H. Lundbeck A/S Method for the preparation of citalopram
US6310222B1 (en) 1999-11-01 2001-10-30 Sumika Fine Chemicals Co., Ltd. Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
EA003581B1 (ru) * 2000-12-22 2003-06-26 Х.Лундбекк А/С Способ получения чистого циталопрама
AU2001100399B4 (en) 2000-12-28 2002-03-21 H Lundbeck As Process for the preparation of pure citalopram
US6781003B1 (en) * 2003-06-09 2004-08-24 Aurobindo Pharma Ltd. Preparation of pure citalopram

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319073A1 (es) * 2005-06-22 2009-05-01 H. Lundbeck A/S Base cristalina de escitalopram y comprimidos orodispersables que comprenden la base de escitalopram.
ES2319073B1 (es) * 2005-06-22 2010-02-26 H. Lundbeck A/S Base cristalina de escitalopram y comprimidos orodispersables que comprenden la base de escitalopram.

Also Published As

Publication number Publication date
GB0105981D0 (en) 2001-05-02
IES20010632A2 (en) 2002-03-06
NO313047B1 (no) 2002-08-05
PL353369A1 (pl) 2003-11-17
CA2359810A1 (en) 2001-07-05
IES20010253A2 (en) 2002-03-06
HUP0102818A3 (en) 2003-07-28
JP2003519121A (ja) 2003-06-17
PT1181272E (pt) 2003-01-31
EP1181272A2 (en) 2002-02-27
GR20010100131A (el) 2002-10-09
MXPA01013336A (es) 2002-07-09
SK18472001A3 (sk) 2002-05-09
US20020087012A1 (en) 2002-07-04
DE60100016T2 (de) 2003-04-17
ITMI20010604A1 (it) 2002-09-22
CH691536A5 (de) 2001-08-15
AT4368U1 (de) 2001-06-25
KR100430746B1 (ko) 2004-05-10
SE0103044L (sv) 2002-06-29
FR2818977B1 (fr) 2003-12-05
FI20010501A0 (fi) 2001-03-13
GB2356199A (en) 2001-05-16
EA003459B1 (ru) 2003-06-26
GB0117095D0 (en) 2001-09-05
BG106219A (bg) 2002-08-30
SK284418B6 (sk) 2005-04-01
ES2170733B1 (es) 2003-12-16
US20030178295A1 (en) 2003-09-25
ATE222899T1 (de) 2002-09-15
FI108640B (fi) 2002-02-28
DE60100016D1 (de) 2002-10-02
DK1181272T3 (da) 2002-12-30
ITMI20010604A0 (it) 2001-03-22
CZ293140B6 (cs) 2004-02-18
BE1013417A6 (fr) 2001-12-04
EA200200016A1 (ru) 2002-04-25
AU3920201A (en) 2001-07-09
BR0106271A (pt) 2002-05-21
TR200200018T1 (tr) 2002-06-21
WO2001047877A2 (en) 2001-07-05
HK1049332A1 (zh) 2003-05-09
WO2001047877A3 (en) 2001-12-27
NL1017534C1 (nl) 2001-04-26
IS5884A (is) 2002-06-28
NO20011272D0 (no) 2001-03-13
UA71635C2 (uk) 2004-12-15
HUP0102818A2 (hu) 2001-12-28
HRP20020005A2 (en) 2003-04-30
AR029898A1 (es) 2003-07-23
GB2361697A (en) 2001-10-31
AU750006B1 (en) 2002-07-11
HU0101028D0 (en) 2001-05-28
KR20020073379A (ko) 2002-09-26
US6855834B2 (en) 2005-02-15
CZ2001891A3 (cs) 2002-08-14
FI20011578A0 (fi) 2001-07-26
GB2356199B (en) 2001-10-03
NO20011272L (no) 2002-07-01
CN1366526A (zh) 2002-08-28
CA2359810C (en) 2002-11-05
HU0102818D0 (en) 2001-09-28
NZ516299A (en) 2002-12-20
AU2001100399B4 (en) 2002-03-21
ZA200110133B (en) 2003-01-13
AU2001100399A4 (en) 2001-11-01
FI109023B (fi) 2002-05-15
FR2818977A1 (fr) 2002-07-05
IL147162A0 (en) 2002-08-14
ES2170733A1 (es) 2002-08-01
EP1181272B1 (en) 2002-08-28
BE1013316A6 (fr) 2001-11-06
SE0103044D0 (sv) 2001-09-14

Similar Documents

Publication Publication Date Title
ES2181663T3 (es) Procedimiento para la preparacion de citalopram puro.
WO2001045483A3 (en) Method for the preparation of pure citalopram
Pattenden et al. Enantioselective synthesis of 2-alkyl substituted cysteines
EE200200572A (et) Pertsükvinniin, selle valmistamismeetod, kandseene liik ja farmatseutiline kompositsioon
ES2167604T3 (es) Eliminacion de impurezas carbonilo de una corriente de un procedimiento de carbonilacion.
CR8975A (es) Proceso para la produccion de derivados de amina opticamente activos
JPS5223017A (en) Process for purification of (meth) acrylic acid or its esters
AR012346A1 (es) Proceso para la fabricacion de compuestos racemicos, compuestos obtenidos por dicho proceso y compuestos intermediarios
MX2024004049A (es) Metodo para producir compuesto o sal farmaceuticamente aceptable del mismo.
Ballini et al. Ring cleavage of cyclic 2-nitroketones by KF catalyst: a general synthesis of ω-nitroacids and ω-nitroesters
CO4980899A1 (es) Proceso para la sintesis de los compuestos intermediarios de cloropurina
RU95103392A (ru) Способ получения 1-гидроксиадамантана
JPS5732245A (en) Production of alpha,omega-alkanedicarboxylic acid
AR035073A1 (es) Un procedimiento para preparar un derivado de distamicina y un compuesto intermedio
FR2860230B1 (fr) Nouveau procede de preparation du cis-octahydro-isoindole
EP1362842A4 (en) PROCESS FOR PREPARING 2-FLUORO-3-OX-O-CYLCARBOXYLIC ACID ESTERS
AR011775A1 (es) Proceso para el aislamiento de eteres y oxima azabiciclo de alta pureza z, en un solo recipiente
RU93039131A (ru) СПОСОБ ПОЛУЧЕНИЯ НАСЫЩЕННОГО ДИМЕРА α-МЕТИЛСТИРОЛА
JPS5841838A (ja) リグナン類の製造方法
JPS5687548A (en) Preparation of alpha,beta-dihalogenopropionitrile
DE60008642D1 (de) Verfahren zur Herstellung von optisch aktiven N-geschützten N-Methyl-phenylalanin-Derivaten
JPS55164651A (en) Preparation of alpha,alpha,alpha-trichloro-o-toluoyl chloride
RU93045150A (ru) Способ получения производных 3-(3,5-дитрет-бутилфенил)тиопропионовой кислоты
RU93047782A (ru) Способ получения циклогексил-изопропил-бензола
WO2002032843A3 (en) Process for the purification of cyclopropanecarboxaldehyde